Co-ordinator and Principle investigator in the following research programs:
 General Secretariat of Research and Technology Ministry of Development of Greece 2000-2001.
 Ioannina University Research Commission 2001-2002 "New with organotin and organo-Germanic derivatives of heterocyclic thione that act either as bacteriostatic or as anti-cancer drugs»
 The research program "Heraklitos" of the Operational Program for Education and Initial Vocational Training of the Hellenic Ministry of Education under the 3rd Community Support Framework and the European Social Fund. 2002-2005
 NATO-Russia Collaborative Linkage Grant (NRCLG) 2008-2010 “ΝEW METALLOTHERAUPEUTICS WITH POSSIBLE BIOLOGICAL ACTIVITY.
 1/1/2010 - today University of Ioannina Research Committee: «Elemental Analysis Center of the Department of Chemistry of the University of Ioannina».
 2014 – 2016 Joseph and Esther Ganis Fountation “New metal-drugs containing non-steroidal anti-inflammatory drugs (NSAIDs). Design and development of new smart materials with improved properties accumulation and bioavailability”
 2014- today Help pharmaceuticals “Design and development of new small molecules against human breast cancer”
 2014-2016: National Scholarships Foundation of Greece (IKY) fellowship of excellence Program-Siemens (project number 22957) "ANTICANCER PROPERTIES OF METAL COMPLEXES COMPOUNDS IN CHEMICAL AND BIOLOGICAL MODELS
 2017-2020: Onassis Foundation "Chemically Modified Steroids Anti-Inflammatory Drugs and / or Steroid Hormones. Design and Development of New Agents for Targeted Breast Cancer Chemotherapy ».
 2018-2021 EU- Program under the "RESEARCH - CREATIVE" Action, which is part of the Operational Program "COMPETITIVENESS, ENTREPRENEURSHIP & INNOVATION" (EPANEK) 2014-2020
 2018- 2021 National Scholarships Foundation of Greece (IKY) "Targeted anti-cancer activity of the antibiotic ciprofloxacin following chemical modification with tin (Sn)"
 2020-2022: National Scholarships Foundation of Greece (IKY) (MIS 5033021), "Design and Development of Innovative Liposomes Containing Mitochondrial Apoptotic Activators for Apoptosis for Targeted Chemotherapy of Breast Cancer"
 2020- 2021 Research Program Financed from Novartis Hellas " Conjugation of antibiotics with organometallic derivatives into a single entity for the development of new chemotherapeutic agents for the treatment of breast cancer
 2022-2023 Human Resources Development Operational Program, Education and Lifelong Learning program "Supporting Higher Education Internationalization Actions.”, Development of the international PhD Program in “Biological Inorganic Chemistry”